|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of CTI BioPharma (NASDAQ: CTIC) through any online brokerage.
The latest price target for CTI BioPharma (NASDAQ: CTIC) was reported by Needham on December 1, 2021. The analyst firm set a price target for 5.00 expecting CTIC to rise to within 12 months (a possible 126.24% upside). 3 analyst firms have reported ratings in the last year.
The stock price for CTI BioPharma (NASDAQ: CTIC) is $2.21 last updated Fri Jan 21 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for CTI BioPharma.
CTI BioPharma’s $Q4 earnings are confirmed for after-market on March 16, 2022.
There is no upcoming split for CTI BioPharma.
CTI BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.